Most signaling pathways in pan-cancer, including ACTB, FLNA, MYH9, MYH10, and TLN1, exhibited high activation levels in the epithelial-mesenchymal transition (EMT) pathway, but consistent inhibition of the cell cycle, DNA damage response, and hormone AR (Figure 3A). The gene discussed is ACTB; the disease is cancer.